Nektar Therapeutics (NASDAQ:NKTR) Earns Market Perform Rating from William Blair
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report)‘s stock had its “market perform” rating reissued by analysts at William ...
Fintel on MSN15h
Oppenheimer Upgrades Nektar Therapeutics (NKTR)
Fintel reports that on March 14, 2025, Oppenheimer upgraded their outlook for Nektar Therapeutics (NasdaqCM:NKTR) from ...